ExodusPoint Capital Management, LP
Position in LRMR — Larimar Therapeutics, Inc.
CIK 1736225
NEW YORK, NY
Position in LRMR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$275,759
+$156,757 QoQ
Shares Held
90,413
+241.9% QoQ
Ownership
0.087%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#59
of 163 holders
Holding Since
Dec 2020
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LRMR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ExodusPoint Capital Management, LP holds $280,525,216 across 101 Biotechnology names. LRMR ranks #81 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CYTK |
Cytokinetics Inc
|
249,259 | $21,234,374 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
224,927 | $16,752,562 | |
| 3 | ORKA |
Oruka Therapeutics, Inc.
|
148,212 | $14,105,336 | |
| 4 | VKTX |
Viking Therapeutics, Inc.
|
361,126 | $14,087,525 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
53,201 | $12,819,844 | |
| 6 | NAMS |
NewAmsterdam Pharma Co N.V.
|
304,334 | $10,313,879 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
164,513 | $9,038,344 | |
| 8 | DNLI |
Denali Therapeutics Inc.
|
336,567 | $8,656,503 |
All Filings in LRMR
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $275,759 | 90,413 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $119,002 | 26,445 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $1,311,577 | 344,246 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $525,911 | 162,821 | Shares | Sole | 2025-11-14 | |
| 2024-09-30 | $138,329 | 21,119 | Shares | Sole | 2024-11-12 | |
| 2021-03-31 | $535,193 | 36,632 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,271,882 | 59,406 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||